31 research outputs found
FamĂlies botĂ niques de plantes medicinals
Get PDFFacultat de Farmà cia, Universitat de Barcelona. Ensenyament: Grau de Farmà cia, Assignatura: Botà nica Farmacèutica, Curs: 2013-2014, Coordinadors: Joan Simon, Cèsar Blanché i
Maria Bosch.Els materials que aquĂ es presenten sĂłn els recull de 175 treballs d’una famĂlia botĂ nica d’interès medicinal realitzats de manera individual. Els treballs han estat realitzat
per la totalitat dels estudiants dels grups M-2 i M-3 de l’assignatura Botà nica Farmacèutica
durant els mesos d’abril i maig del curs 2013-14. Tots els treballs s’han dut a terme a través de la plataforma de GoogleDocs i han estat tutoritzats pel professor de l’assignatura i revisats i finalment co-avaluats entre els propis estudiants. L’objectiu principal de l’activitat ha estat fomentar l’aprenentatge autònom i col·laboratiu en Botà nica farmacèutica
Studio in vitro dell'attivitĂ spontanea e indotta da alfa-interferone delle cellule NK in pazienti uremici emodializzati e in trapiantati renali.
No full textNatural Killer activity in kidney allograft recipients and in uremic hemodialyzed patients:in vitro effect of alfa-interferon.
No full textACMIA versus MEIA assay in therapeutical monitoring of Sirolimus
No full textBackground: Sirolimus (Rapamune, Wyeth-Ayerst, Princeton, USA), is a macrolide antibiotic inhibitor of mammalian target of rapamycin (mTOR-i) with antiproliferative and immunosuppressant properties. This drug has a narrow therapeutic index and individual farmacokinetic variability requiring blood monitoring. The HPLC-MS is the referring method for blood sirolimus assay although immunoassay systems are widely used in therapeutic drugs monitoring. In this study we compare the sirolimus determinations using the Microparticle Enzyme Immunoassay (MEIA) run on the IMx analyser (Abbott) with the recently introduced Affinity Column- Mediated Immunoassay (ACMIA), run on the Dimension Xpand (Siemens Corporation, Deerfield,USA). Aim of our study was to evaluate the performance of ACMIA method, that has the advantage of not requiring pre-treatment procedure, compared to the MEIA method
OKT3 PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS: DRUG MONITORING BY FLOW CYTOMETRY
No full text[No abstract available
AttivitĂ natural killer in soggetti sottoposti a trapianto di rene:valutazione del numero degli efettori.dell'azione dell'interferone e delle infezioni.
No full textValutazione clinica del monitoraggio delle sottopopolazioni linfocitarie nei pazienti trapiantati di rene.
No full textRole of the indirect recognition pathway in the development of chronic liver allograft rejection
No full textPresence of HLA-Class I specific T suppressor (Ts) cells in kidney allograft recipients.
No full textVolume 54,Supplemento 1, July/August 2001, Scandinavian Journal of Immunology
A POINT-OF-CARE PRESEPSIN ASSAY FOR THE EVALUATION OF SEPSIS IN CRITICAL CARE UNIT PATIENTS. PRELIMINARY STUDY
No full text
